237 related articles for article (PubMed ID: 32064890)
1. Does axillary lymph node size predict better metastatic involvement than apparent diffusion coefficient (ADC) value in women with newly diagnosed breast cancer?
Ramírez-Galván YA; Cardona-Huerta S; Elizondo-Riojas G; Álvarez-Villalobos NA; Campos-Coy MA; Ferrara-Chapa CM
Acta Radiol; 2020 Nov; 61(11):1494-1504. PubMed ID: 32064890
[TBL] [Abstract][Full Text] [Related]
2. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
3. Assessment of axillary lymph nodes in patients with breast cancer with diffusion-weighted MR imaging in combination with routine and dynamic contrast MR imaging.
Razek AA; Lattif MA; Denewer A; Farouk O; Nada N
Breast Cancer; 2016 May; 23(3):525-32. PubMed ID: 25763535
[TBL] [Abstract][Full Text] [Related]
4. Diffusion tensor imaging and diffusion-weighted imaging on axillary lymph node status in breast cancer patients.
Kurt N; Binboga Kurt B; Gulsaran U; Uslu B; Celik AO; Sut N; Tastekin E; Karabulut D; Tuncbilek N
Diagn Interv Radiol; 2022 Jul; 28(4):329-336. PubMed ID: 35950277
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
Guvenc I; Whitman GJ; Liu P; Yalniz C; Ma J; Dogan BE
Breast J; 2019 Jan; 25(1):47-55. PubMed ID: 30444286
[TBL] [Abstract][Full Text] [Related]
6. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.
Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y
J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of T2-weighted imaging and intravoxel incoherent motion diffusion-weighted MRI for predicting metastatic axillary lymph nodes in T1 and T2 stage breast cancer.
Liu Y; Luo H; Wang C; Chen X; Wang M; Zhou P; Ren J
Acta Radiol; 2022 Apr; 63(4):447-457. PubMed ID: 33779304
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging features for predicting axillary lymph node metastasis in patients with breast cancer.
Zhao M; Wu Q; Guo L; Zhou L; Fu K
Eur J Radiol; 2020 Aug; 129():109093. PubMed ID: 32512504
[TBL] [Abstract][Full Text] [Related]
9. Diffusion weighted images of metastatic as compared with nonmetastatic axillary lymph nodes in patients with newly diagnosed breast cancer.
Yamaguchi K; Schacht D; Nakazono T; Irie H; Abe H
J Magn Reson Imaging; 2015 Sep; 42(3):771-8. PubMed ID: 25556886
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of breast MRI for predicting metastatic axillary lymph nodes in breast cancer patients: diffusion-weighted MRI and conventional MRI.
Kim EJ; Kim SH; Kang BJ; Choi BG; Song BJ; Choi JJ
Magn Reson Imaging; 2014 Dec; 32(10):1230-6. PubMed ID: 25072504
[TBL] [Abstract][Full Text] [Related]
12. Discrimination of axillary metastatic from nonmetastatic lymph nodes with PROPELLER diffusion-weighted MR imaging in a metastatic breast cancer model and its correlation with cellularity.
Junping W; Tongguo S; Yunting Z; Chunshui Y; Renju B
J Magn Reson Imaging; 2012 Sep; 36(3):624-31. PubMed ID: 22570219
[TBL] [Abstract][Full Text] [Related]
13. MRI-based predictive factors of axillary lymph node status in breast cancer.
Atallah D; Moubarak M; Arab W; El Kassis N; Chahine G; Salem C
Breast J; 2020 Nov; 26(11):2177-2182. PubMed ID: 33073463
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of preoperative breast magnetic resonance imaging with a dedicated axillary sequence for the detection of axillary lymph node metastasis in patients with early ductal breast cancer.
Ahn HS; Jang M; Kim SM; La Yun B; Lee SH
Radiol Med; 2019 Dec; 124(12):1220-1228. PubMed ID: 31422573
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.
Fornasa F; Nesoti MV; Bovo C; Bonavina MG
J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570
[TBL] [Abstract][Full Text] [Related]
16. Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer.
Kato F; Kudo K; Yamashita H; Baba M; Shimizu A; Oyama-Manabe N; Kinoshita R; Li R; Shirato H
Breast Cancer; 2019 Sep; 26(5):628-636. PubMed ID: 30937834
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.
Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK
Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.
Schipper RJ; Paiman ML; Beets-Tan RG; Nelemans PJ; de Vries B; Heuts EM; van de Vijver KK; Keymeulen KB; Brans B; Smidt ML; Lobbes MB
Radiology; 2015 May; 275(2):345-55. PubMed ID: 25513854
[TBL] [Abstract][Full Text] [Related]
19. Suspicious axillary lymph nodes identified on clinical breast MRI in patients newly diagnosed with breast cancer: can quantitative features improve discrimination of malignant from benign?
Rahbar H; Conlin JL; Parsian S; DeMartini WB; Peacock S; Lehman CD; Partridge SC
Acad Radiol; 2015 Apr; 22(4):430-8. PubMed ID: 25491740
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the diagnostic performance of apparent diffusion coefficient (ADC) values on diffusion-weighted magnetic resonance imaging (DWI) in differentiating between benign and metastatic lymph nodes in cases of cholangiocarcinoma.
Promsorn J; Soontrapa W; Somsap K; Chamadol N; Limpawattana P; Harisinghani M
Abdom Radiol (NY); 2019 Feb; 44(2):473-481. PubMed ID: 30151713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
